What Makes Teva Pharmaceuticals (TEVA) a Successful Brand?

6 days ago 4

Soumya Eswaran

Thu, January 29, 2026 astatine 9:05 AM CST 3 min read

Greenlight Capital, an concern absorption company, released its fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. Greenlight Capital’s concern strategy focuses connected constructing a bottom-up portfolio comprising undervalued agelong positions and overvalued abbreviated positions, portion besides including a macro publication to hedge risks and seizure insights. The Partnership returned 9.0% (net) successful 2025 compared to 17.9% for the S&P 500 index. In contrast, it returned 8.5% successful Q4, compared to 2.7% for the index. The Partnership has returned $6.1 billion, nett of fees and expenses, to its investors since its inception successful May 1996. For much accusation connected the Partnership’s apical picks successful 2025, delight cheque its apical 5 holdings.

In its fourth-quarter 2025 capitalist letter, Greenlight Capital highlighted stocks similar Teva Pharmaceutical Industries Limited (NYSE:TEVA). Teva Pharmaceutical Industries Limited (NYSE:TEVA) is an Israel-based pharmaceutical company. Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares traded betwixt $12.47 and $33.42 implicit the past 52 weeks. On January 28, 2026, Teva Pharmaceutical Industries Limited (NYSE:TEVA) banal closed astatine $33.21 per share. One-month instrumentality of Teva Pharmaceutical Industries Limited (NYSE:TEVA) was 7.08%, and its shares gained 66.85% of their worth implicit the past 3 months. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has a marketplace capitalization of $36.63 billion.

Greenlight Capital stated the pursuing regarding Teva Pharmaceutical Industries Limited (NYSE:TEVA) successful its 4th fourth 2025 capitalist letter:

"Teva Pharmaceutical Industries Limited (NYSE:TEVA): The institution continued to present accelerated maturation successful its patented branded portfolio, with results consistently exceeding expectations. The marketplace began to bespeak this advancement lone aft argumentation headwinds eased, including a negotiated pricing statement with the Centers for Medicare & Medicaid Services for TEVA’s cause Austedo opening successful 2027. These developments much than offset muted show successful the generics concern and item the advancement TEVA has made successful its modulation to a branded pharmaceutical company."

Among Small-Cap Healthcare Stocks Hedge Funds is Buying

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 60 hedge money portfolios held Teva Pharmaceutical Industries Limited (NYSE:TEVA) astatine the extremity of the 3rd quarter, up from 57 successful the erstwhile quarter. While we admit the imaginable of Teva Pharmaceutical Industries Limited (NYSE:TEVA) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.